In summary, this study indicated that DCM is associated with oxidative stress and mitochondrial dysfunction, and that EMPA protects against DCM through effectively inhibiting oxidative stress by activating Nrf2 and its downstream antioxidant genes and improving mitochondrial function via inhibiting mitochondrial fragmentation. The gene discussed is NFE2L2; the disease is familial dilated cardiomyopathy.